JDRF launches online service to connect people with diabetes with clinical trial information

July 29, 2009

NEW YORK, NY, July 29, 2009 - The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide and the largest charitable funder and advocate of type 1 research, announced today that it has launched an on-line service for people with type 1 diabetes and their families to easily find information about clinical trials for drugs, treatments, and therapeutics for diabetes and its complications.

The on-line service, JDRF's Clinical Trials Connection, will enable people to search the database of trials of the National Institutes of Health (including JDRF-funded trials) that involve diabetes cures and treatments to get information, make comparisons, and - if they are interested - directly contact trial centers. It is available at www.trials.jdrf.org.

Through this web site, people can provide criteria like the type of trial they are interested in, how long they have had diabetes, and how far they'd be willing to travel, and the site will let them know about studies that match those characteristics. Clinical Trials Connection can help them search for trials, compare one trial with another, and update them on new trials that might match their interest. Plus, the service provides contact information for the researchers conducting the trial, so people interested in trials can contact them directly for more information, after discussing options with their healthcare provider.

The quickly increasing number of clinical trials, and the overall progress in diabetes research, make it harder for people with diabetes to keep up-to-date on what trials are available, and to make decisions on whether or not to participate in a study. People tell JDRF a simple-to-use service to find and compare trials would be a significant benefit to them; in fact, more than 5,000 people have pre-registered for the site.

At the same time, Clinical Trials Connection will help advance JDRF's research agenda, which is funding more human clinical trials than ever before, but finding it tougher and tougher to enroll participants in a timely and cost-efficient way.

Over its almost 40 years of history, the Juvenile Diabetes Research Foundation International has funded more than $1.3 billion in research to find a cure for type 1 diabetes, accelerating the pace of science leading to a cure to the point where it is today funding more than 40 human clinical trials of drugs, compounds, and therapeutics.

But what should be terrific news for the almost 3 million people in the U.S. with this life-long autoimmune disease, is only bittersweet, as diabetes researchers are finding it difficult to recruit enough participants to take part in trials quickly and cost-effectively.

Among a number of ways to promote the free service, JDRF is focusing one of its public service announcement advertisements on encouraging people to take part in the search for a cure by finding out about clinical trial opportunities. The theme of the campaign is "What does hope look like?" The answer is that it looks like children and adults with type 1 diabetes taking an active role in science leading to a cure.

The campaign includes 60-second and 30-second television and radio spots, as well as print, billboard, and online banner ads. They feature Mary Tyler Moore, the International Chairman of JDRF who was diagnosed with type 1 diabetes as an adult, and a group of children, teens, and adults with diabetes who have taken part in clinical trials. The campaign launched earlier this year.

The ads direct people with type 1 diabetes and their families to JDRF's Clinical Trials Connection.

In type 1 diabetes, the immune systems stops a person's pancreas from producing insulin, the hormone that enables people to get energy from food. To survive, people with type 1 diabetes must test their blood sugar levels multiple times per day by pricking their fingers to draw blood, and then administering insulin through multiple daily injections, or the use of a continuous infusion insulin pump.

While trying to balance insulin with the amount of food eaten (which raises blood sugar) and exercise (which lowers blood sugar), people with type 1 diabetes must constantly be prepared for potential life-threatening low or high blood sugar levels. Just as devastating, the long-term complications of diabetes include blindness, heart attack, kidney failure, stroke, nerve damage and amputations. While usually diagnosed in childhood, type 1 diabetes can also be diagnosed in adults.
About JDRF

JDRF is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder and advocate of type 1 research. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is a disease which strikes children and adults suddenly and requires multiple injections of insulin daily or a continuous infusion of insulin through a pump. Insulin, however, is not a cure for diabetes, nor does it prevent its eventual and devastating complications which may include kidney failure, blindness, heart disease, stroke, and amputation.

Since its founding in 1970 by parents of children with type 1 diabetes, JDRF has awarded more than $1.3 billion to diabetes research, including more than $100 million in FY2008.


Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.